I C U Medical Inc (ICUI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 86,870 | 101,035 | 28,793 | 68,644 | 63,084 |
| Depreciation Amortization | 86,150 | 77,339 | 75,077 | 66,720 | 20,405 |
| Accounts receivable | 78,049 | -23,684 | -76,742 | -54,533 | 744 |
| Accounts payable and accrued liabilities | -46,415 | -2,697 | 23,270 | 46,648 | -463 |
| Other Working Capital | -16,966 | -111,636 | -32,716 | 51,066 | -8,755 |
| Other Operating Activity | 35,064 | 61,561 | 142,533 | -24,122 | 14,926 |
| Operating Cash Flow | $222,752 | $101,918 | $160,215 | $154,423 | $89,941 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -26,040 | -30,496 | N/A | N/A |
| PPE Investments | -85,829 | -97,279 | -78,955 | -74,477 | -20,093 |
| Net Acquisitions | N/A | -76,133 | -1,300 | -162,448 | -2,584 |
| Purchase Of Investment | -32,825 | N/A | N/A | -24,743 | -118,384 |
| Sale Of Investment | 28,900 | 41,292 | 15,440 | N/A | 158,534 |
| Purchase Sale Intangibles | -8,385 | -8,728 | -8,059 | -5,203 | -1,192 |
| Other Investing Activity | -8,385 | -8,728 | -8,059 | -5,203 | -1,192 |
| Investing Cash Flow | $-98,139 | $-166,888 | $-103,370 | $-266,871 | $16,281 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 150,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -357 | N/A | N/A | -75,000 | N/A |
| Common Stock Issued | 13,193 | 7,732 | 14,275 | 34,708 | 19,707 |
| Common Stock Repurchased | N/A | N/A | N/A | -4,057 | -17,235 |
| Other Financing Activity | -162,876 | -18,639 | -6,252 | 0 | 0 |
| Financing Cash Flow | $-40 | $-10,907 | $8,023 | $-44,349 | $2,472 |
| Exchange Rate Effect | 2,854 | -234 | -10,159 | 1,787 | 224 |
| Beginning Cash Position | 268,670 | 344,781 | 290,072 | 445,082 | 336,164 |
| End Cash Position | 396,097 | 268,670 | 344,781 | 290,072 | 445,082 |
| Net Cash Flow | $127,427 | $-76,111 | $54,709 | $-155,010 | $108,918 |
| Free Cash Flow | |||||
| Operating Cash Flow | 222,752 | 101,918 | 160,215 | 154,423 | 89,941 |
| Capital Expenditure | -92,005 | -97,312 | -92,720 | -74,479 | -23,361 |
| Free Cash Flow | 130,747 | 4,606 | 67,495 | 79,944 | 66,580 |